Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • World
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (Zephyr)
  • No Skin
Collapse
Peptide Critic Community Peptide Critic Community
  1. Peptide Forum
  2. Peptide Discussion
  3. Apileen13XR - weight loss pep which activates 4 receptors?
Prize
Peptide Critic Case and Pens
Ends in
1065 entries · 489 participants
Enter →

Apileen13XR - weight loss pep which activates 4 receptors?

Scheduled Pinned Locked Moved Peptide Discussion
18 Posts 8 Posters 289 Views 1 Watching
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • mmpM Offline
    mmpM Offline
    mmp
    wrote last edited by
    #1

    BLL started to sell their weight loss pep.
    https://biolongevitylabs.com/product/apileen13xr/

    According to the last video with Mike Farber, that is a mixture of longlasting Reta with Apelin-13

    1 Reply Last reply
    1
    • vpepsV Online
      vpepsV Online
      vpeps
      wrote last edited by
      #2

      It is, although they are trying to concentrate solely on 5 mcg Apileen-13 LR component and ignore 160 mcg of "Lepto" component, probably to avoid a conflict with a certain company.

      attentiion is all you need

      1 Reply Last reply
      2
      • Stan DouglasS Offline
        Stan DouglasS Offline
        Stan Douglas
        wrote last edited by
        #3

        Aaaaaand Reta is outdated. This is the reason I don't stalk up on GLP and why pharmacies will never compete.

        M 1 Reply Last reply
        3
        • ResearchCatR Online
          ResearchCatR Online
          ResearchCat
          wrote last edited by
          #4

          I’d want to see a lot more information on this before trying it out. What is dosing? Effectiveness? I’ve been waiting for NA-931 (bioglutide) for a while now.

          Yeah, well, I’m just here for the research, man. - The Dude

          If I haven’t liked your post, no offense. I have exceeded my daily allowance.

          vpepsV 1 Reply Last reply
          0
          • M Online
            M Online
            mikebricker
            wrote last edited by
            #5

            I have some Snake Oil that should work just as good if not better…. 😉

            1 Reply Last reply
            1
            • ResearchCatR ResearchCat

              I’d want to see a lot more information on this before trying it out. What is dosing? Effectiveness? I’ve been waiting for NA-931 (bioglutide) for a while now.

              vpepsV Online
              vpepsV Online
              vpeps
              wrote last edited by
              #6

              @ResearchCat I know for the dosing they suggest to start with 20 mcg every week, and you may go up to 40 mcg a week. They claim it gives you energy for the exercise and burns fat at higher doses.

              attentiion is all you need

              1 Reply Last reply
              1
              • dontfyourlifeD Offline
                dontfyourlifeD Offline
                dontfyourlife
                wrote last edited by
                #7

                Well, to take a cautious optimistic outlook....

                So far zero human or animal studies evaluating how a specific two peptide blend affects weight loss. Now Apelin-13 has been researched except....those trials focused on heart, lung and kidney diseases.

                Oddly the majority of info published on this comes from Biolongevity themselves 🙂

                1 Reply Last reply
                0
                • Stan DouglasS Stan Douglas

                  Aaaaaand Reta is outdated. This is the reason I don't stalk up on GLP and why pharmacies will never compete.

                  M Offline
                  M Offline
                  MikeMiranda
                  wrote last edited by
                  #8

                  @Stan-Douglas said:

                  Aaaaaand Reta is outdated. This is the reason I don't stalk up on GLP and why pharmacies will never compete.

                  I am waiting for Elora prices to come down a little

                  M 1 Reply Last reply
                  0
                  • M MikeMiranda

                    @Stan-Douglas said:

                    Aaaaaand Reta is outdated. This is the reason I don't stalk up on GLP and why pharmacies will never compete.

                    I am waiting for Elora prices to come down a little

                    M Online
                    M Online
                    mikebricker
                    wrote last edited by
                    #9

                    @MikeMiranda Loretta, the quad agonist. Elora plus Reta. Hard to beat that. 😉

                    M 1 Reply Last reply
                    1
                    • M mikebricker

                      @MikeMiranda Loretta, the quad agonist. Elora plus Reta. Hard to beat that. 😉

                      M Offline
                      M Offline
                      MikeMiranda
                      wrote last edited by MikeMiranda
                      #10

                      @mikebricker said:

                      @MikeMiranda Loretta, the quad agonist. Elora plus Reta. Hard to beat that. 😉

                      I know, I'm just waiting. I am currently running Reta and Tirz, but I will be stopping Tirz soon and doing Reta/Cagri. I am kinda sad I didn't get the Loretta from YuanTi; it was $100 a kit.

                      1 Reply Last reply
                      0
                      • J Online
                        J Online
                        jennn
                        wrote last edited by
                        #11

                        I’m all for peps (especially the ones that have been used for 15-20 years), but I don’t know if I’ll trade my well established and studied GLP1 class for a brand new and completely untested alternative. And it’s likely to be way more expensive through only one source, if BLL keeps it away from the copy cats.

                        vpepsV 1 Reply Last reply
                        2
                        • J jennn

                          I’m all for peps (especially the ones that have been used for 15-20 years), but I don’t know if I’ll trade my well established and studied GLP1 class for a brand new and completely untested alternative. And it’s likely to be way more expensive through only one source, if BLL keeps it away from the copy cats.

                          vpepsV Online
                          vpepsV Online
                          vpeps
                          wrote last edited by
                          #12

                          @jennn a minus is that it's not tested as well as Reta, a plus is that it has 19 days half-life vs. 6 days and the dosages are 100 times smaller, which may mean a lot less side-effects for a similar formulation.

                          attentiion is all you need

                          mmpM 1 Reply Last reply
                          0
                          • vpepsV vpeps

                            @jennn a minus is that it's not tested as well as Reta, a plus is that it has 19 days half-life vs. 6 days and the dosages are 100 times smaller, which may mean a lot less side-effects for a similar formulation.

                            mmpM Offline
                            mmpM Offline
                            mmp
                            wrote last edited by
                            #13

                            @vpeps

                            If it's the same formula with longer half-life, less side effects = less main effects

                            vpepsV J 2 Replies Last reply
                            0
                            • mmpM mmp

                              @vpeps

                              If it's the same formula with longer half-life, less side effects = less main effects

                              vpepsV Online
                              vpepsV Online
                              vpeps
                              wrote last edited by vpeps
                              #14

                              @mmp not necessary. If the main effect is achieved with a low dose there may be no side effects with this dose. But if also the half life is short, one way to extend the main effect is to increase the dose many times, so it degrades longer. But the larger dose may show the side effects that are not there with a small dose.

                              attentiion is all you need

                              1 Reply Last reply
                              0
                              • mmpM mmp

                                @vpeps

                                If it's the same formula with longer half-life, less side effects = less main effects

                                J Online
                                J Online
                                jennn
                                wrote last edited by
                                #15

                                @mmp I’m super skeptical about anything Mike Farber is putting out. I hate the way he describes Klotho in terms of its kidney utility. I’m a nephrologist, and it’s quite clear he has NO idea what he is talking about. Not that it may not work in some ways in some situations, but he just has no idea how to delineate tubular interstial disease from glomerular disease, and that’s dangerous to people who look to this for CKD. Maybe he stumbled onto something good with FLGR and this new quad4 drug, but I have a feeling he’s really getting ahead of his skis. And Jay Campbell and Trevor Kruder are getting swept up in the excitement of it all.

                                vpepsV 1 Reply Last reply
                                1
                                • J jennn

                                  @mmp I’m super skeptical about anything Mike Farber is putting out. I hate the way he describes Klotho in terms of its kidney utility. I’m a nephrologist, and it’s quite clear he has NO idea what he is talking about. Not that it may not work in some ways in some situations, but he just has no idea how to delineate tubular interstial disease from glomerular disease, and that’s dangerous to people who look to this for CKD. Maybe he stumbled onto something good with FLGR and this new quad4 drug, but I have a feeling he’s really getting ahead of his skis. And Jay Campbell and Trevor Kruder are getting swept up in the excitement of it all.

                                  vpepsV Online
                                  vpepsV Online
                                  vpeps
                                  wrote last edited by vpeps
                                  #16

                                  @jennn It will be interesting to hear a professional opinion on it and see how it develops. I tried his a-Klotho-LR product for 8 weeks at the dose he suggested. Klotho is easy to overdose, there are other Klotho proteins on sale and also Klotho-peptides, but they are short-working and you can't guess your levels. I liked a-Klotho-LR because it is strictly low-dosed matching your natural Klotho levels and stays 19 days bound to albumin, which is a great solution to this problem.
                                  At that point I was also taking other things like GHRH so I can't just blame a-Klotho-LR, but my eGFR level (cystatin-c based) went from 110s to 70s, and it had never been at those levels before, for many years of testing. I stopped all the interventions and it slowly went up over 6 weeks, now at 97. At this point I decided to try a-Klotho-LR again and will check in a month or two, maybe it was a coincidence. I also did a blood check for Klotho before I restarted, and it showed a very low level of it. It is not a mainstream lab though and the testing technology may be not perfect. Too many unknowns.

                                  attentiion is all you need

                                  J 1 Reply Last reply
                                  0
                                  • vpepsV vpeps

                                    @jennn It will be interesting to hear a professional opinion on it and see how it develops. I tried his a-Klotho-LR product for 8 weeks at the dose he suggested. Klotho is easy to overdose, there are other Klotho proteins on sale and also Klotho-peptides, but they are short-working and you can't guess your levels. I liked a-Klotho-LR because it is strictly low-dosed matching your natural Klotho levels and stays 19 days bound to albumin, which is a great solution to this problem.
                                    At that point I was also taking other things like GHRH so I can't just blame a-Klotho-LR, but my eGFR level (cystatin-c based) went from 110s to 70s, and it had never been at those levels before, for many years of testing. I stopped all the interventions and it slowly went up over 6 weeks, now at 97. At this point I decided to try a-Klotho-LR again and will check in a month or two, maybe it was a coincidence. I also did a blood check for Klotho before I restarted, and it showed a very low level of it. It is not a mainstream lab though and the testing technology may be not perfect. Too many unknowns.

                                    J Online
                                    J Online
                                    jennn
                                    wrote last edited by
                                    #17

                                    @vpeps I could go on about the design of kidney function trials, but that’s not important. Changes in cre or CystC can cut both ways. It’s not that simple. My skepticism with him and his line of 200 rando drug patents is that he can’t even coherently explain a mechanism of action that makes any medical sense.
                                    Now this albumin binding protein that’s supposed to increase the half life of these drugs, maybe that’s something. But I don’t know if I buy this Apileen13 thing if there’s already an additional 3 receptor agonist baked in with it.

                                    vpepsV 1 Reply Last reply
                                    1
                                    • J jennn

                                      @vpeps I could go on about the design of kidney function trials, but that’s not important. Changes in cre or CystC can cut both ways. It’s not that simple. My skepticism with him and his line of 200 rando drug patents is that he can’t even coherently explain a mechanism of action that makes any medical sense.
                                      Now this albumin binding protein that’s supposed to increase the half life of these drugs, maybe that’s something. But I don’t know if I buy this Apileen13 thing if there’s already an additional 3 receptor agonist baked in with it.

                                      vpepsV Online
                                      vpepsV Online
                                      vpeps
                                      wrote last edited by vpeps
                                      #18

                                      @jennn If you look at COA on their page, also read the description, you will see that this is 160 mcg of a version of retatrutide with an increased affinity binding to albumin, that basically hangs onto it all its 19 day life, and a separate 5 mcg molecule of the same albumin binder attached to apileen-13 molecule, which is ampk activator. It's a nice combo. Their alpha klotho uses a similar strong binder.

                                      I wouldn't recommend though to buy it at least now. They got a lot of it in stock and will run a bigger sale likely on black friday in a few weeks if you want to research it.

                                      attentiion is all you need

                                      1 Reply Last reply
                                      1

                                      Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                      Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                      With your input, this post could be even better 💗

                                      Register Login
                                      Reply
                                      • Reply as topic
                                      Log in to reply
                                      • Oldest to Newest
                                      • Newest to Oldest
                                      • Most Votes


                                      • Login

                                      • Login or register to search.
                                      • First post
                                        Last post
                                      0
                                      • Categories
                                      • Recent
                                      • Tags
                                      • Popular
                                      • World
                                      • Users
                                      • Groups